Lasa Supergenerics Limited
NSE:LASA.NS
29.12 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,043.35 | 1,295.678 | 1,371.267 | 2,023.795 | 1,672.566 | 1,695.73 | 2,435.259 | 1,996.625 | 0 |
| Cost of Revenue
| 922.32 | 1,061.143 | 920.16 | 1,136.935 | 955.136 | 1,289.212 | 1,744.454 | 1,335.531 | 0 |
| Gross Profit
| 121.03 | 234.535 | 451.107 | 886.86 | 717.43 | 406.518 | 690.805 | 661.094 | 0 |
| Gross Profit Ratio
| 0.116 | 0.181 | 0.329 | 0.438 | 0.429 | 0.24 | 0.284 | 0.331 | 0 |
| Reseach & Development Expenses
| 1.317 | 1.022 | 2.023 | 3.736 | 3.381 | 1.643 | 2.153 | 1.698 | 0 |
| General & Administrative Expenses
| 65.773 | 35.706 | 43.063 | 39.96 | 19.458 | 19.05 | 18.27 | 3.074 | 0 |
| Selling & Marketing Expenses
| 0.657 | 20.978 | 19.203 | 29.693 | 31.162 | 9.844 | 9.601 | 13.09 | 0 |
| SG&A
| 206.098 | 56.684 | 62.266 | 69.653 | 50.62 | 28.894 | 27.871 | 16.164 | 0 |
| Other Expenses
| 0.993 | 18.046 | 0.109 | 0.087 | 486.742 | 3.181 | 423.44 | 275.837 | 0 |
| Operating Expenses
| 206.098 | 434.661 | 426.389 | 572.448 | 559.824 | 484.278 | 459.678 | 292.001 | 0 |
| Operating Income
| -85.068 | -180.986 | 47.471 | 314.411 | 155.825 | -78.401 | 231.236 | 369.093 | 0 |
| Operating Income Ratio
| -0.082 | -0.14 | 0.035 | 0.155 | 0.093 | -0.046 | 0.095 | 0.185 | 0 |
| Total Other Income Expenses Net
| -106.057 | -241.665 | -108.862 | -19.497 | -108.464 | -82.627 | -78.903 | -399.255 | 0 |
| Income Before Tax
| -191.125 | -422.651 | -62.096 | 294.914 | 47.361 | -161.028 | 152.333 | -30.162 | 0 |
| Income Before Tax Ratio
| -0.183 | -0.326 | -0.045 | 0.146 | 0.028 | -0.095 | 0.063 | -0.015 | 0 |
| Income Tax Expense
| 26.181 | -36.444 | -8.424 | 67.137 | 11.077 | -40.722 | 28.934 | -23.909 | 0 |
| Net Income
| -217.306 | -386.207 | -53.672 | 227.777 | 36.284 | -120.306 | 123.399 | -6.253 | 0 |
| Net Income Ratio
| -0.208 | -0.298 | -0.039 | 0.113 | 0.022 | -0.071 | 0.051 | -0.003 | 0 |
| EPS
| -4.34 | -7.71 | -1.07 | 5.6 | 0.89 | -5.26 | 5.43 | -0.3 | 0 |
| EPS Diluted
| -4.34 | -7.71 | -1.07 | 5.6 | 0.89 | -5.26 | 5.43 | -0.3 | 0 |
| EBITDA
| 21.658 | -47.889 | 157.576 | 470.516 | 320.656 | 141.787 | 428.7 | 364.196 | 0 |
| EBITDA Ratio
| 0.021 | -0.037 | 0.115 | 0.232 | 0.192 | 0.084 | 0.176 | 0.182 | 0 |